•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Vitrolife AB (publ) reported first-quarter sales of SEK 807 million (842), representing an increase of 5% in local currencies but a 4% decrease when translated into SEK.
Sales per region, measured in local currencies, were -1% in EMEA, +11% in the Americas, and +7% in APAC.
By product group, sales in local currencies increased by +9% in Consumables, +11% in Technologies, and declined by -1% in Genetics.
Gross margin rose to 59.9% (57.4).
Earnings before depreciation and amortisation (EBITDA) amounted to SEK 251 million (257), corresponding to an EBITDA margin of 31.1% (30.6).
Net income was SEK 101 million (100), resulting in earnings per share of SEK 0.74 (0.74).
Operating cash flow increased to SEK 172 million (69).
Gothenburg, April 23, 2026. This disclosure contains information that Vitrolife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation (EU No 596/2014). The information was submitted for publication on 23-04-2026 at 08:00 CET.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
